Stock 603882 GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Guangzhou Kingmed Diagnostics Group Co., Ltd.

Equities

603882

CNE100002VW1

Healthcare Facilities & Services

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-28 pm EDT 		5-day change 1st Jan Change
40.3 CNY +5.77% Intraday chart for Guangzhou Kingmed Diagnostics Group Co., Ltd. -10.14% -35.59%
Apr. 25 Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 25 Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration

Latest news about Guangzhou Kingmed Diagnostics Group Co., Ltd.

Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on January 20, 2024. CI
Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback announced on January 20, 2024, has closed with 1,781,400 shares, representing 0.38% for CNY 99.99 million. CI
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on January 20, 2024. CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares. CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. authorizes a Buyback Plan. CI
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on December 19, 2023. CI
Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback announced on December 19, 2023, has closed with 1,696,800 shares, representing 0.36% for CNY 99.99 million. CI
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on December 19, 2023. CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares. CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. authorizes a Buyback Plan. CI
Guangzhou Kingmed Diagnostics Group Co., Ltd.(SHSE:603882) dropped from SSE 180 Index CI
Guangzhou Kingmed Diagnostics Group Co., Ltd.(SHSE:603882) dropped from Shanghai Stock Exchange 180 Value Index CI
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on September 19, 2023. CI
Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback announced on September 19, 2023, has closed with 787,600 shares, representing 0.17% for CNY 49.99 million. CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on September 19, 2023. CI
China's Small Hospitals, Clinics Banking on AI to Bridge Barriers in Diagnosis, Treatment MT
Kingmed Diagnostics to Repurchase Up to 50 Million Yuan Shares MT
Guangzhou Kingmed Diagnostics Group Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares. CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. authorizes a Buyback Plan. CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Guangzhou Xinhongrui Investment Consulting Partnership (Limited Partnership), Guangzhou Xinhongyu Investment Consulting Partnership (Limited Partnership), Guangzhou Xinhongyu Investment Consulting Partnership (Limited Partnership) and Xie Jiangtao agreed to acquire 72% stake in Guangzhou Jinli Pharmaceutical Technology Co., Ltd. from Guangzhou Kingmed Diagnostics Group Co., Ltd. for CNY 220 million. CI
GeneMind Biosciences Company Limited announced that it has received CNY 400 million in funding from Guangzhou Kingmed Diagnostics Group Co., Ltd., Shanghai Guoxin Investment Development Co. Ltd., Shenzhen High-Tech Investment Group Co., Ltd., Changzhou Shuangye Venture Capital, Hunan Caixin Capital Management Co., Ltd., Guochuang Zhiyuan Private Equity Fund CI

Chart Guangzhou Kingmed Diagnostics Group Co., Ltd.

Chart Guangzhou Kingmed Diagnostics Group Co., Ltd.
More charts

Company Profile

Guangzhou Kingmed Diagnostics Group Co Ltd is a company that mainly provides medical diagnosis services. The Company is also engaged in other businesses, including sales of diagnostic products, provision of physical examination and cold chain logistics services.
Sector
Healthcare Facilities & Services
Calendar
2024-05-20 - Annual General Meeting
More about the company

Income Statement Evolution

More financial data

Ratings for Guangzhou Kingmed Diagnostics Group Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
40.3 CNY
Average target price
72.66 CNY
Spread / Average Target
+80.29%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

1st Jan change Capi.
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-35.59% 2.61B
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-16.55% 8.43B
RADNET, INC. Stock RadNet, Inc.
+40.93% 3.62B
SYNLAB AG Stock SYNLAB AG
-8.06% 2.48B
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
-7.90% 2.34B
NEOGENOMICS, INC. Stock NeoGenomics, Inc.
-5.93% 1.94B
FLEURY S.A. Stock Fleury S.A.
-18.96% 1.56B
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-38.35% 1.26B
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+6.91% 1.1B
ADICON HOLDINGS LIMITED Stock Adicon Holdings Limited
-10.43% 1.03B
Medical & Diagnostic Laboratories
  1. Stock Market
  2. Equities
  3. 603882 Stock
  4. News Guangzhou Kingmed Diagnostics Group Co., Ltd.
  5. UBS Adjusts Guangzhou Kingmed Diagnostics’ Price Target to 97.20 Yuan From 98 Yuan, Keeps at Buy